United States Biotechnology & Medical Research

Mustang Bio Inc (MBIO)

Track

Ticker: MBIO Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Mustang Bio Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 30 Dec 2025
Value US$1,291,688.94 | Price 369.08 | Shares 84,013 (+42.7%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-30 2025-12-30 S Sale
2.4
Chill Adam J.
Non-Executive Director
84,013 +42.7%
369.08
US$1,291,689 		84,013 +42.7% 369.08 US$1,291,689
2025-12-30 2025-12-30 S Sale
1.8
Herskowitz Neil
Non-Executive Director
77,517 -28.8%
233.90
US$4,781,139 		77,517 -28.8% 233.90 US$4,781,139
2025-12-30 2025-12-30 B Purchase
1.3
Jin David
Non-Executive Director
84,328 -48.5%
235.13
US$3,398,604 		84,328 -48.5% 235.13 US$3,398,604
2023-04-03 2022-09-13 PP Planned purchase
3.9
ROSENWALD LINDSAY A MD
Non-Executive Director
5,000 +1.7%
0.52
US$2,582 		5,000 +1.7% 0.52 US$2,582
2023-04-03 2022-09-13 PP Planned purchase
3.1
Litchman Manuel MD
Non-Executive Director
5,000 +0.5%
0.52
US$2,582 		5,000 +0.5% 0.52 US$2,582
2023-04-03 2022-03-18 PP Planned purchase
3.9
ROSENWALD LINDSAY A MD
Non-Executive Director
4,094 +1.9%
0.74
US$3,025 		4,094 +1.9% 0.74 US$3,025
2023-04-03 2022-03-18 PP Planned purchase
3.1
Litchman Manuel MD
Non-Executive Director
5,000 +0.5%
0.74
US$3,695 		5,000 +0.5% 0.74 US$3,695
2021-12-16 2021-12-14 S Sale
3.1
Achenbach Brian

SVP, Fin. & Corp. Controller

Officer
4,374 -2.9%
1.83
US$8,004 		4,374 -2.9% 1.83 US$8,004
2021-11-08 2021-10-27 B Purchase
3.1
Litchman Manuel MD

President and CEO

Executive Director
65,000 +6.7%
2.24
US$145,600 		65,000 +6.7% 2.24 US$145,600
2021-10-21 2021-10-12 S Sale
3.1
Achenbach Brian

SVP, Fin. & Corp. Controller

Officer
4,450 -3.4%
2.28
US$10,146 		4,450 -3.4% 2.28 US$10,146
2021-04-16 2021-04-09 S Sale
3.1
Achenbach Brian

SVP, Fin. & Corp. Controller

Officer
2,423 -1.8%
3.36
US$8,141 		2,423 -1.8% 3.36 US$8,141
2021-03-15 2021-03-05 B Purchase
3.1
Litchman Manuel MD

President and CEO

Executive Director
165,562 +25.1%
3.12
US$516,553 		165,562 +25.1% 3.12 US$516,553
2020-12-22 2020-12-15 B Purchase
3.1
Litchman Manuel MD

President and CEO

Executive Director
100,000 +18.0%
2.91
US$291,000 		100,000 +18.0% 2.91 US$291,000
2020-12-15 2020-12-14 B Purchase
3.9
ROSENWALD LINDSAY A MD
Non-Executive Director
100,000 +99.6%
2.66
US$266,000 		100,000 +99.6% 2.66 US$266,000
2021-04-16 2020-12-08 S Sale
3.1
Achenbach Brian

SVP, Fin. & Corp. Controller

Officer
5,185 -3.7%
3.03
US$15,711 		5,185 -3.7% 3.03 US$15,711
2021-04-16 2020-10-21 S Sale
3.1
Achenbach Brian

SVP, Fin. & Corp. Controller

Officer
3,056 -2.2%
2.97
US$9,076 		3,056 -2.2% 2.97 US$9,076
2020-06-15 2020-06-11 B Purchase
3.1
Litchman Manuel MD

President and CEO

Executive Director
153,846 +45.9%
3.25
US$500,000 		153,846 +45.9% 3.25 US$500,000
2021-04-29 2020-05-22 S Sale
3.1
Litchman Manuel MD

President and CEO

Executive Director
8,348 -1.0%
3.04
US$25,378 		8,348 -1.0% 3.04 US$25,378
2021-04-29 2020-05-22 S Sale
3.1
Litchman Manuel MD

President and CEO

Executive Director
4,025 -0.5%
3.04
US$12,236 		4,025 -0.5% 3.04 US$12,236
2021-04-16 2020-05-22 S Sale
3.1
Achenbach Brian

SVP, Fin. & Corp. Controller

Officer
880 -0.6%
3.04
US$2,675 		880 -0.6% 3.04 US$2,675
2020-05-22 2020-05-21 B Purchase
3.1
Litchman Manuel MD

President and CEO

Executive Director
90,000 +36.7%
3.13
US$281,700 		90,000 +36.7% 3.13 US$281,700
2020-05-22 2020-05-14 B Purchase
3.1
Litchman Manuel MD

President and CEO

Executive Director
90,000 +58.1%
2.79
US$251,100 		90,000 +58.1% 2.79 US$251,100
2021-04-16 2020-03-31 S Sale
3.1
Achenbach Brian

SVP, Fin. & Corp. Controller

Officer
3,033 -2.1%
2.64
US$8,007 		3,033 -2.1% 2.64 US$8,007
2021-04-16 2019-12-06 S Sale
3.1
Achenbach Brian

SVP, Fin. & Corp. Controller

Officer
6,144 -4.0%
3.69
US$22,671 		6,144 -4.0% 3.69 US$22,671
2018-12-18 2018-12-10 B Purchase Litchman Manuel MD

President and CEO

Executive Director
8,000 +40.0%
3.35
US$26,805 		8,000 +40.0% 3.35 US$26,805
2018-12-18 2018-12-04 B Purchase Litchman Manuel MD

President and CEO

Executive Director
7,500 +60.0%
3.60
US$27,000 		7,500 +60.0% 3.60 US$27,000
2018-12-18 2018-11-26 B Purchase Litchman Manuel MD

President and CEO

Executive Director
5,000 +66.7%
3.87
US$19,354 		5,000 +66.7% 3.87 US$19,354
2018-12-07 2018-11-23 B Purchase Herskowitz Neil Non-Executive Director
1,000 +1.4%
3.96
US$3,960 		1,000 +1.4% 3.96 US$3,960
2018-12-18 2018-11-21 B Purchase Litchman Manuel MD

President and CEO

Executive Director
5,000 +200.0%
4.21
US$21,048 		5,000 +200.0% 4.21 US$21,048
2018-12-18 2018-11-20 B Purchase Litchman Manuel MD

President and CEO

Executive Director
2,500 +inf%
3.89
US$9,720 		2,500 +inf% 3.89 US$9,720
2018-12-03 2018-11-20 B Purchase Achenbach Brian

VP, Fin. & Corp. Controller

Officer
500 +0.9%
3.87
US$1,937 		500 +0.9% 3.87 US$1,937
2018-12-03 2018-11-19 B Purchase Achenbach Brian

VP, Fin. & Corp. Controller

Officer
1,000 +1.8%
4.25
US$4,250 		1,000 +1.8% 4.25 US$4,250
2018-12-03 2018-11-16 B Purchase Achenbach Brian

VP, Fin. & Corp. Controller

Officer
1,000 +1.8%
4.31
US$4,310 		1,000 +1.8% 4.31 US$4,310
2018-11-05 2018-11-02 B Purchase ROSENWALD LINDSAY A MD Non-Executive Director
50,000 +250.0%
4.41
US$220,500 		50,000 +250.0% 4.41 US$220,500
Explore more

More insider trading research around Mustang Bio Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America